VCYT - VERACYTE, INC.

QQQ $ 473.83 $ 0.25 (0.05 %)

DIA $ 417.12 $ -0.12 (-0.03 %)

SPY $ 563.14 $ 0.23 (0.04 %)

TLT $ 100.82 $ -0.49 (-0.48 %)

GLD $ 237.35 $ -1.32 (-0.55 %)

Previous Close

$ 34.32

Open

$ 34.13

Bid

$ 34.31 x 100

Ask

-- x --

Day's Range

$ 34.09 - $ 34.97

52 Week Range

$ 18.61 - $ 34.99

Volume

887,939

Average Volume

Market Cap

2.64B

Beta (5Y Monthly)

$ 1.74

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-05-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	07-29-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	02-22-2021	12-31-2020	10-K
16	11-02-2020	09-30-2020	10-Q
17	07-30-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-25-2020	12-31-2019	10-K
20	10-22-2019	09-30-2019	10-Q
21	07-30-2019	06-30-2019	10-Q
22	04-30-2019	03-31-2019	10-Q
23	02-25-2019	12-31-2018	10-K
24	10-29-2018	09-30-2018	10-Q
25	07-23-2018	06-30-2018	10-Q
26	05-01-2018	03-31-2018	10-Q
27	02-27-2018	12-31-2017	10-K
28	11-07-2017	09-30-2017	10-Q
29	07-31-2017	06-30-2017	10-Q
30	05-03-2017	03-31-2017	10-Q
31	03-01-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-03-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	03-14-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-13-2015	06-30-2015	10-Q
38	05-15-2015	03-31-2015	10-Q
39	03-25-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Sunday, Data Presented At ESMO 20...
09/16/2024 07:02:19

Findings are from ancillary study of phase 3 STAMPEDE trial Data support company's plan to expand Decipher Prostate test...

Needham Maintains Buy on Veracyte, Raises ...
08/28/2024 09:29:55

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $31 to $37.

Morgan Stanley Maintains Underweight on Ve...
08/12/2024 17:33:25

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and raises the price target from $21...

lumen-tech--upstart-are-among-top-7-mid-cap-gainers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

Lumen Tech & Upstart Are Among Top 7 Mid C...
08/11/2024 19:32:19

Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in...

diagnostic-tests-maker-veracytes-q2-is-all-around-very-good-quarter-analysts-maintain-bullish-view

Diagnostic Tests Maker Veracyte's Q2 Is 'A...
08/07/2024 18:08:44

Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue ...

shopify-posts-upbeat-earnings-joins-axon-enterprise-aspen-technology-illumina-global-payments-and-other-big-stocks-moving-higher-on-wednesday

Shopify Posts Upbeat Earnings, Joins Axon ...
08/07/2024 15:05:22

Needham Maintains Buy on Veracyte, Raises ...
08/07/2024 10:35:45

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $27 to $31.

Veracyte Q2 2024 Adj. EPS $0.30 Beats $(0....
08/06/2024 20:16:07

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.02) by 1...

cathie-wood-lead-ark-invest-dumps-76m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-choppiness

Cathie Wood-Lead Ark Invest Dumps $7.6M Wo...
06/11/2024 02:28:34

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). ...

Veracyte Reports Research Using Afirma GRI...
06/03/2024 20:07:38

A Glimpse Into The Expert Outlook On Verac...
05/08/2024 15:00:33

Needham Maintains Buy on Veracyte, Lowers ...
05/08/2024 12:14:43

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $33 to $27.

Veracyte Q1 2024 GAAP EPS $(0.02) Beats $(...
05/07/2024 22:17:19

Veracyte (NASDAQ:VCYT) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.17) by 8...

Veracyte Raises FY24 Revenue From $394M-$4...
05/07/2024 21:39:52

Veracyte Announces Data From 14 Studies Pr...
05/06/2024 20:30:52

Large number of abstracts also showcases power of the Veracyte Diagnostics PlatformVeracyte, Inc. (NASDAQ:VCYT), a leading canc...

Veracyte's New Study Shows The Decipher Pr...
04/22/2024 12:42:54

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision...

Veracyte Announces 9 Abstracts Reinforcing...
04/16/2024 12:42:48

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher...

Goldman Sachs Maintains Buy on Veracyte, L...
04/15/2024 14:33:35

Goldman Sachs analyst Matthew Sykes maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $32 to $28.

cathie-woods-ark-invest-dumps-17m-in-coinbase-shares-as-the-exchange-grappled-with-disruption-amid-bitcoin-rally

Cathie Wood's Ark Invest Dumps $17M In Coi...
02/29/2024 04:02:13

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASD...

cathie-woods-ark-invest-sheds-93m-worth-of-coinbase-shares-amid-bitcoin-rally--robinhood-stock-also-sold

Cathie Wood's Ark Invest Sheds $9.3M Worth...
02/28/2024 03:35:54

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.